BUCHANG PHARMA(SH:603858) Hua Er Jie Jian Wen·2025-09-16 10:39Investment Overview - The investment is made by the subsidiary Shanghai HePu Medical Technology Co., Ltd. with a total investment amount of 4.9 million yuan using its own funds [1] - Two new companies are established: Shandong HePu RuiCheng Medical Technology Co., Ltd. and Hubei HePu Medical Technology Co., Ltd. [1] Investment Structure - Shandong HePu RuiCheng has a registered capital of 4 million yuan, with Shanghai HePu contributing 2.8 million yuan (70% ownership) and Jinan Hengde Technology contributing 1.2 million yuan (30% ownership) [1] - Hubei HePu Medical has a registered capital of 3 million yuan, with Shanghai HePu contributing 2.1 million yuan (70% ownership) and Shanghai Guoding Technology contributing 900,000 yuan (30% ownership) [1] Partner Information - Jinan Hengde Technology has a registered capital of 550,000 yuan, primarily engaged in medical equipment leasing and sales, with a projected net profit of -393,300 yuan in 2024 and 332,200 yuan in the first half of 2025 [1] - Shanghai Guoding Technology has a registered capital of 1 million yuan, with a projected net profit of -3,000 yuan in 2024 and -25,000 yuan in the first half of 2025 [1] Approval Status - The investment has been approved by the board of directors and does not require submission to the shareholders' meeting [1] - The investment does not constitute a related party transaction or a major asset restructuring [1]